Biotech

All Articles

Recursion's brain condition test presents scant proof of efficacy

.Recursion has actually discovered with a very early examination of its own tech-enabled technique t...

Acepodia, Pfizer click all together for chemistry-based cell treatment

.Call it an instance of good chemistry: Acepodia, a biotech based on Nobel Champion scientific resea...

Praxis epilepsy medication lowers seizures in phase 2 trial

.Practice Preciseness Medicines has actually racked up an additional midphase win in epilepsy this y...

Three execs resign as Dyne blog posts mixed records for DMD prospect

.After running away a medical hold many years back, Dyne Therapy has actually uncovered brand new pe...

Arrowhead fires off stage 3 data in unusual metabolic illness in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has actually presented its hand in front of a potential showdown with Ion...

Pfizer, Valneva show lyme condition go efficient for second enhancer

.Pfizer and Valneva may possess about pair of even more years to wait before they create the 1st app...

Fierce Biotech Managing Editor Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Permit's dive into a talk along with Ayla Ellison, Intense Biotech Editor-in-Chief as well as Miche...

New data show how Bayer's asundexian fell short to avoid strokes

.Bayer suspended the period 3 test for its own variable XIa prevention asundexian late in 2014 after...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS trials

.Sanofi is still bented on taking its own numerous sclerosis (MS) med tolebrutinib to the FDA, manag...

Galapagos' stock up as fund shows intent to shape its own evolution

.Galapagos is actually coming under additional tension coming from investors. Having created a 9.9% ...